(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester

(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Suppliers list
Company Name: GL Biochem (Shanghai) Ltd  
Tel: 21-61263452 13641803416
Email: ymbetter@glbiochem.com
Company Name: Accela ChemBio Co.,Ltd.  
Tel: 4000665055
Email: marketing@accelachem.com
Company Name: Heterochem  
Tel: 027-88041443 13072715837
Email: sales@hetero-chem.com
Company Name: T&W GROUP  
Tel: 021-61551611 13296011611
Email: contact@trustwe.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: 021-58170097
Email: info@topbiochem.com

(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester manufacturers

(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Basic information
Uses
Product Name:(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester
Synonyms:(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester;tert-Butyl [(1R)-1-(4-bromophenyl)ethyl]carbamate;tert-butyl N-[(1R)-1-(4-broMophenyl)ethyl]carbaMate;(R)-N-Boc-1-(4-broMophenyl)ethylaMine;tert-butyl (R)-1-(4-bromophenyl)ethylcarbamate;Carbamic acid, N-[(1R)-1-(4-bromophenyl)ethyl]-, 1,1-dimethylethyl ester;(R)-tert-butyl (1-(4-broMophenyl)ethyl)carbaMate
CAS:578729-21-2
MF:C13H18BrNO2
MW:300.19
EINECS:
Product Categories:
Mol File:578729-21-2.mol
(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Structure
(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Chemical Properties
Melting point 131-135 ºC
Boiling point 383.1±25.0 °C(Predicted)
density 1.282
storage temp. 2-8°C
pka11.94±0.46(Predicted)
AppearanceWhite to off-white Solid
Safety Information
MSDS Information
(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Usage And Synthesis
Uses[(1R)-1-(4-bromophenyl)ethyl] tert-butyl carbamate is a carboxylic acid ester organic compound that can be used as a pharmaceutical intermediate.
Synthesis
Di-tert-butyl dicarbonate

24424-99-5

4-Bromo-alpha-phenethylamine

24358-62-1

(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester

578729-21-2

General procedure for the synthesis of tert-butyl [(1R)-1-(4-bromophenyl)ethyl]carbamate from di-tert-butyl dicarbonate and 1-(4-bromophenyl)ethylamine: 1. 1-(4-Bromophenyl)ethylamine (1.0 g, 5 mmol) was dissolved in methanol (10 ml) and sodium bicarbonate (1.26 g, 15.0 mmol) and di-tert-butyl dicarbonate (1.2 g, 5.5 mmol) were added. 2. The reaction mixture was sonicated for 4 hours. 3. The solvent was evaporated and the residue partitioned between ethyl acetate and water. 4. The organic phase was washed with brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure to afford tert-butyl [(1R)-1-(4-bromophenyl)ethyl]carbamate (1.8 g, 6.0 mmol, 120%) as a white solid. 5. tert-Butyl [(1R)-1-(4-bromophenyl)ethyl]carbamate (0.73 g, 2.4 mmol) was dissolved in 1,2-dimethoxyethane (10 ml), tetrakis(triphenylphosphine)palladium (0.14 g, 0.12 mmol), 2-chloro-pyridinyl-3-boronic acid (0.77 g, 4.9 mmol), and 2 M sodium carbonate solution were added. 6. The reaction mixture was heated to reflux for 16 h. The solvent was removed under reduced pressure. 7. The residue was partitioned between ethyl acetate and water. 8. The organic phase was washed with brine, dried over anhydrous magnesium sulfate and the solvent was removed under reduced pressure. 9. The residue was separated by chromatography on silica gel, eluting with 3:1 heptane/ethyl acetate, and the solvent was removed under reduced pressure to afford tert-butyl (1R)-1-[4-(2-chloropyridin-3-yl)phenyl]ethylcarbamate (0.56 g, 1.7 mmol, 71%) as an off-white solid. 10. tert-Butyl (1R)-1-[4-(2-chloropyridin-3-yl)phenyl]ethylcarbamate (100 mg, 0.3 mmol), sodium ethoxide (61 mg, 0.9 mmol) and tetrahydrofuran (5 ml) were heated and refluxed under argon atmosphere for 16 hours. 11. The solvent was evaporated and the residue was purified on a SCX column eluting with a methanol solution of 2M ammonia to give (1R)-1-[4-(2-ethoxypyridin-3-yl)phenyl]ethylamine (66 mg, 0.27 mmol, 90%) as a yellow gel. 12. (1R)-1-[4-(2-ethoxypyridin-3-yl)phenyl]ethylamine (13 mg, 0.05 mmol) was dissolved in dichloromethane (1 ml), triethylamine (17 mg, 0.16 mmol) and 2-(trifluoromethoxy)benzenesulfonyl chloride (17 mg, 0.065 mmol) were added. 13. The reaction mixture was stirred for 16 hours and the solvent was evaporated under reduced pressure. 14. The crude product was dissolved in dimethyl sulfoxide (1 ml) and purified by preparative LCMS. 15. The solvent was evaporated under reduced pressure to give the title compound (6 mg, 0.013 mmol, 26%). 1H NMR (400MHz, DMSO-d6): δ 8.42 (d, 1H), 8.13 (dd, 1H), 7.81 (dd, 1H), 7.63 (m, 2H), 7.39 (m, 4H), 7.24 (d, 2H), 7.05 (m, 1H), 4.48 (q, 1H), 4.36 (q, 2H), 1.35 (d , 3H), 1.29 (t, 3H) ppm; MS (ESI) m/z: 467 [M + H]+.

References[1] Patent: US2007/149577, 2007, A1. Location in patent: Page/Page column 6-7
[2] European Journal of Medicinal Chemistry, 2019, p. 407 - 422
[3] Patent: WO2006/18725, 2006, A1. Location in patent: Page/Page column 176
[4] Patent: WO2008/68507, 2008, A2. Location in patent: Page/Page column 57
[5] Patent: WO2009/60278, 2009, A1. Location in patent: Page/Page column 48
(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester Preparation Products And Raw materials
Raw materialsDi-tert-butyl dicarbonate-->4-Bromo-alpha-phenethylamine-->Methanol-->Sodium bicarbonate
Preparation Products(1R)-4-(1-BOC-Aminoethyl)phenylboronic acid
Tag:(R)-[1-(4-Bromophenyl)ethyl]carbamic acid tert-butyl ester(578729-21-2) Related Product Information
Isoxadifen-ethyl Ethanol Ethyl acetate Ethyl acrylate Butylparaben tert-Butyl peroxybenzoate Ethylparaben tert-Butyl carbamate Cyhalofop-butyl Isobutyl chloroformate tert-Butyl carbazate Chlorpropham tert-Butyl 4-aminobenzoate Diisobutyl phthalate Buprofezin Methyl acrylate Tris(trimethylsilyl)phosphate Butyl oleate